Global Cancer Biological Therapy Market 2018 Size, Development Status, Type and Application, Segmentation, Forecast by 2023

WiseGuyReports.com adds “Cancer Biological Therapy Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023”reports to its database.

Pune, India - January 12, 2018 /MarketersMedia/ —

Cancer Biological Therapy Market:

Executive Summary

Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. There are various types of biological therapies, which inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.

The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a CAGR of 4.7% during the forecasted period.  

The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.

On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, interferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.

On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023. 

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Players

The leading market players in the global cancer biological therapy market include Merck Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Bristol-Myers Squibb, Celgene, ELI Lilly and Company, EnGeneIC, and Pfizer

Study objectives

To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global cancer biological therapy market
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global cancer biological therapy market.
To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
To provide economical factors that influences the global cancer biological therapy market
To provide detailed analysis of the value chain and supply chain of the global cancer biological therapy market

Target Audience

Pharmaceutical Companies
Pharmaceutical Suppliers
Cancer Research Organizations
Potential Investors
Key Executive (CEO and COO) and Strategy Growth Manager
Reaserch Companies

For further information on this report, visit - https://www.wiseguyreports.com/enquiry/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Findings

North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016

The reports also covers regional analysis

North America
o US

o Canada

Europe
o Germany

o France

o U.K.

o Italy

o Spain

o Rest of Europe

Asia Pacific
o Japan

o China

o India

o Republic of Korea

o Rest of Asia-Pacific

Middle East & Africa
o Middle East

o Africa

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1793685

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: Wise Guy Research Consultants Pvt Ltd
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349 (US); +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/global-cancer-biological-therapy-market-2018-size-development-status-type-and-application-segmentation-forecast-by-2023/286775

For more information, please visit https://www.wiseguyreports.com/reports/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Source: MarketersMedia

Release ID: 286775

Latest News

Summer drinks may lack fizz amid carbon dioxide shortage

Jun 20, 2018

LONDON — A British trade group says there's a shortage of carbon dioxide in Northern Europe, sparking fears that drinks may lack fizz just as thirsty soccer fans fill pubs for the World Cup. Gavin Partington, director-general of the British Soft Drinks Association, says the shortage is due to the closure of several production sites for various reasons, including seasonal maintenance. But industry publication Gasworld says the situation is worse this year because normal maintenance has coincided with technical issues at chemical plants that also produce carbon dioxide. That shortage comes just as the World Cup is getting underway in...

Global stocks rise, unfazed by US-China tensions

Jun 20, 2018

SINGAPORE — Asian and European stocks rose on Wednesday as investors rallied around signs that the global economy was on track, amid heated exchanges between the world's two largest economies over trade. KEEPING SCORE: European shares rose in early trading. Germany's DAX rose 0.4 percent to 12,727.61 and France's CAC 40 added 0.3 percent to 5,405.57. Britain's FTSE 100 gained 1.2 percent to 7,695.94. Wall Street was poised to open higher. Dow futures added 0.4 percent to 24,808.00 and broader S&P 500 futures were up 0.3 percent to 2,773.00. ASIA'S DAY: Japan's benchmark Nikkei 225 index rebounded 1.2 percent to...

Asian stocks take breather from trade tension; markets mixed

Jun 20, 2018

SINGAPORE — Asian markets were mixed on Wednesday as traders sidelined tariffs that the U.S. and China have threatened to impose on one another, focusing on positive housing data instead. KEEPING SCORE: Japan's benchmark Nikkei 225 index rose less than 0.1 percent to 22,287.42 and South Korea's Kospi gained 0.9 percent to 2,361.39 in early trading. Hong Kong's Hang Seng increased 0.1 percent to 29,508.83 while the Shanghai Composite in mainland China slipped 0.9 percent to 2,881.33. Australia's S&P/ASX 200 climbed 0.8 percent to 6,149.20. Taiwan's benchmark fell but Southeast Asian indexes were mixed. U.S-CHINA TARIFFS: A burgeoning trade war...

UK reviews medical marijuana ban after outcry over sick kids

Jun 20, 2018

LONDON — The British government announced Tuesday it would move to lift its ban on cannabis-based medicines, amid mounting criticism over the denial of treatment to severely epileptic children. But it rejected calls to legalize marijuana for recreational use. Home Secretary Sajid Javid told lawmakers cases like that of a 12-year-old epileptic boy denied cannabis oil for his condition showed there is "a pressing need to allow those who might benefit from cannabis based medicines to access them." But he said the government had "absolutely no plans" to decriminalize the drug more widely. The change in stance came after the...

NATO's chief appeals for unity amid trans-Atlantic row

Jun 20, 2018

LONDON — NATO's chief is urging the alliance's 29 countries to set aside a festering trans-Atlantic row over trade, climate and the Iran nuclear deal, amid concern that the tensions will undermine the military alliance. In an editorial in Tuesday's Guardian newspaper, NATO Secretary-General Jens Stoltenberg said "the ties that bind us are under strain." He said "we must continue to work hard to settle our differences - and where differences persist, we must limit any negative impact on our security cooperation." Stoltenberg's message comes less than a month before U.S. President Donald Trump meets with his NATO counterparts in...

Financial Markets

Market Sanctum is one of the world’s leading news sources for the currency trading community. Our analysts report on the latest changes in the current market, providing in-depth analysis.

Contact us: sales[at]marketsanctum.com